Project Grant HT9425261E108
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $502K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Fairfax, VA, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Virginia Commonwealth University a $597,556 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through June 30, 2029. The award supports research titled "Native Top-Down Proteomics for Improved Targeting of Growth Factor-Mediated Endocrine Resistance in Breast Cancer," which aims to advance breast cancer diagnostics and therapeutic targeting through...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a Project Grant totaling $699,751 under the Military Medical Research and Development program (CFDA 12.420) for the period May 1, 2026 through April 30, 2029. The grant supports research titled "Unveiling Mechanisms and Innovative Therapies for ESR1-CCDC170 Fusions in Clinically Aggressive, Endocrine-Resistant and Metastatic Breast Cancers," to be conducted at the University's facilities in...
- Federal Grant Award Summary Thomas Jefferson University, operating as Sidney Kimmel Medical College, received a $1,998,484 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2029. The award funds biomedical research titled "Deciphering the Role of PIK3CA Mutations in Tumorigenesis of HER2-Positive Breast Cancer," with research activities conducted at the...
- Federal Grant Award Summary The University of Pittsburgh received a $1.8 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2026, through April 30, 2029. This three-year project supports investigator-initiated biomedical research focused on unveiling mechanisms and developing innovative therapeutic approaches for ESR1-CCDC170 fusions in clinically aggressive, endocrine-resistant, and...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $750,000 Project Grant to the University of California Irvine on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) for the project "A Novel Strategy to Improve the Effectiveness of Radiation Therapy in Breast Cancer." The three-year award period runs through April 30, 2029, and supports investigator-initiated biomedical research addressing medical challenges relevant to Service...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of Melbourne a $1.12M Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective April 1, 2026, through March 31, 2029. The award funds research into novel biological therapies targeting a tumor-specific isoform of HER2 (human epidermal growth factor receptor 2) for the treatment of advanced breast cancer. This three-year research initiative leverages the University of...
- Federal Grant Award Summary McMaster University received a $103,160 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2026. The award supports research focused on understanding the role of fibroblast growth factor 8 (FGF8) in sebaceous gland carcinoma of the eyelid. This one-year investigator-initiated research project will be conducted at McMaster University's facility in...
- Federal Project Grant Award Summary Georgetown University received a $754,873 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026, through June 30, 2029. The project, titled "Targeting WNK1 to Disrupt Cell Volume Control in Triple-Negative Breast Cancer," supports basic and applied biomedical research addressing Service Member health and medical innovation. The research initiative...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $750,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded July 1, 2026, with completion targeted for June 30, 2029. The award supports research to identify and validate novel therapeutic targets designed to overcome treatment resistance in triple-negative breast cancer (TNBC). This research directly aligns with the...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Duke University $696,154 under the Military Medical Research and Development program (CFDA 12.420) to investigate off-target effects of breast cancer adjuvant radiation therapy on thymus function in young women. The three-year project, initiated September 1, 2026 and concluding August 31, 2029, will be conducted at Duke University's Durham, North Carolina facility. The research addresses a critical gap in understanding...